Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect and Mechanism of taVNS in Modulating Human Social Attention

NCT: NCT07798349 · RECRUITING

NCT IDNCT07798349
StatusRECRUITING
Start Date2026-08-01
Completion2026-11-30
SponsorUniversity of Electronic Science and Technology of China (OTHER)
First posted
Last updated

Brief Summary

The objectives of this study are to investigate: 1. whether non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) can enhance human interest in social stimuli in free-viewing and stressful tasks; 2. whether its effect on brain function occurs via modulating endogenous oxytocin release; 3. how the stimulation site and various parameters of taVNS should be set to effectively promote the above-mentioned changes in brain function. The main questions it aims to answer are: 1. Does taVNS facilitate a preference for social relative to non-social stimuli in both free-viewing and stressful tasks? 2. Does taVNS increase peripheral concentrations of the neuropeptide oxytocin, and whether these changes are associated with enhanced social attention? 3. Does taVNS stimulation of the right tragus, left tragus, or bilateral tragus sites produce the strongest effects on oxytocin release and social attention? Investigators will compare the effects of taVNS targeting the left tragus, right tragus, or bilateral tragus with ear-lobe sham stimulation (no vagal activation). Eye-tracking will be used across multiple experimental paradigns. For measurements of oxytocin (OT) and arginine vasopressin (AVP), saliva samples will be collected at baseline, immediately after taVNS, 20 min post-stimulation, and 30 min post-stimulation. Investigators will test whether (a) taVNS facilitates social attention, and (b) its effects are associated with elevated OT and AVP release. Investigators hypothesize that taVNS will enhance social attention and oxytocin release, that changes in social attention will be associated with the magnitude of oxytocin release, and that bilateral tragus stimulation will produce the strongest effects on both social attention and oxytocin release.

Frequently Asked Questions

What is The Effect and Mechanism of taVNS in Modulating Human Social Attention?

The Effect and Mechanism of taVNS in Modulating Human Social Attention is a clinical trial registered under NCT07798349. Current status: RECRUITING.

What is the status of NCT07798349?

The current status of NCT07798349 (The Effect and Mechanism of taVNS in Modulating Human Social Attention) is: RECRUITING.

When did The Effect and Mechanism of taVNS in Modulating Human Social Attention start?

The Effect and Mechanism of taVNS in Modulating Human Social Attention started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.